The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Advances in Rheumatology & Challenges that Remain Spotlighted in ACR Convergence 2021 Closing Session

Advances in Rheumatology & Challenges that Remain Spotlighted in ACR Convergence 2021 Closing Session

December 2, 2021 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF

ACR Convergence graphicACR Convergence 2021—With more than 600 speakers and science presentations and 13,500 participants from 110+ countries, ACR Convergence 2021 gave rheumatologists a global view of advances and challenges within the field of rheumatology. It also managed to connect new and old friends, albeit virtually.

You Might Also Like
  • Opening Session of ACR Convergence 2021 Takes on Burnout, Pandemic Challenges & Moving Toward a New Normal
  • Research on SLE, pJIA & More Highlighted in 2nd ACR Convergence 2021 Plenary Session
  • ACR Convergence 2021: Advocacy Successes & Challenges
Explore This Issue
February 2022
Also By This Author
  • Highlights, Pearls & News from ACR Convergence 2020

During the Closing Session: A Look Beyond: Open Reflection & Future Innovation, speakers shared their thoughts on some of the most illuminating sessions and challenges facing rheumatology.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Taken by Surprise

With the diversity of sessions involved in this year’s ACR Convergence, speakers remarked on sessions with findings that took them by surprise.

Dr. Jennifer Anolik

The role of the microbiome in rheumatoid arthritis (RA) pathogenesis was an interesting and surprising topic for Jennifer Anolik, MD, PhD, a rheumatologist with the University of Rochester Medical Center, New York. An abstract that examined RA patients and mouse models found that researchers could identify a commensal bacteria isolated from RA patients and that these same patients made RA antibodies that interacted with the bacteria. When the bacteria were given to mice, it induced RA.1

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

This type of research may lead toward future therapeutics that can target the microbiome for the emergence of disease and treatment, Dr. Anolik said.

Dr. Hannan

Marian T. Hannan, DSc, MPH, professor of medicine at Harvard Medical School, Cambridge, Mass., and co-director of the Musculoskeletal Research Center and senior scientist, Hinda and Arthur Marcus Institute for Aging Research, Boston, was particularly interested in research related to environmental and social factors. For example, she highlighted sessions that discussed research on climate and pollution as they relate to autoimmunity.

Additionally, Dr. Hannan noted that the ARP Distinguished Lecture by Edward Yelin, PhD, University of California, San Francisco, raised the question of whether being poor makes you sicker or if being sick makes you poor. “Both are true,” Dr. Hannan said, adding that Dr. Yelin talked about outcomes related to lupus and RA as they tie into where patients live, their employment status and the labor market being as important as clinical interventions.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“We tend to focus on treatments and diagnosis, and the interplay that has on our environment and people’s personal circumstances are huge. It underscores how much I don’t think about that, but I should,” Dr. Hannan said.

Findings related to multisystem inflammatory syndrome in children (MIS-C) were of interest to Erica Lawson, MD, a pediatric rheumatologist at University of California, San Francisco, as children with MIS-C fill patient wards. One update supported the idea that glucocorticoids plus intravenous immunoglobulin (IVIG) is a better treatment option than IVIG alone to treat those with MIS-C, she said.

Pages: 1 2 3 | Single Page

Filed Under: ACR Convergence, Conditions, Meeting Reports, Rheumatoid Arthritis Tagged With: ACR Convergence 2021Issue: February 2022

You Might Also Like:
  • Opening Session of ACR Convergence 2021 Takes on Burnout, Pandemic Challenges & Moving Toward a New Normal
  • Research on SLE, pJIA & More Highlighted in 2nd ACR Convergence 2021 Plenary Session
  • ACR Convergence 2021: Advocacy Successes & Challenges
  • COVID-19, New Research & More: 2 Experts Discuss Scientific Advances in Rheumatology at ACR Convergence 2020

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)